Showing results (91-100 of 97) with videos related to
Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
The Lancet. Infectious Diseases|May 31, 2024
Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trialCissy Kityo, Ivan K Mambule, Joseph Musaazi, et al.The Journal of Infectious Diseases|March 25, 2024
Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation TrialNicholas I Paton, Meera Gurumurthy, Qingshu Lu, et al.The New England Journal of Medicine|February 22, 2023
Treatment Strategy for Rifampin-Susceptible TuberculosisNicholas I Paton, Christopher Cousins, Celina Suresh, et al.The Lancet. Infectious Diseases|May 25, 2025
Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trialNicholas I Paton, Christopher Cousins, Intan P Sari, et al.The New England Journal of Medicine|July 12, 2014
Assessment of second-line antiretroviral regimens for HIV therapy in AfricaNicholas I Paton, Cissy Kityo, Anne Hoppe, et al.The Journal of Clinical Investigation|June 15, 2021
Doxycycline host-directed therapy in human pulmonary tuberculosisQing Hao Miow, Andres F Vallejo, Yu Wang, et al.Bulletin of the World Health Organization|July 29, 2024
Target regimen profiles for tuberculosis treatmentChristian Lienhardt, Kelly E Dooley, Payam Nahid, et al.Pageof 10